Multidisciplinary management of adult anaplastic astrocytomas

被引:7
作者
Chang, S
Theodosopoulos, P
Sneed, P
机构
[1] Univ San Francisco, Dept Radiat Oncol, San Francisco, CA 94117 USA
[2] Univ San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA
关键词
D O I
10.1053/srao.2001.21428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The management of patients with anaplastic astrocytoma (AA) requires multidisciplinary involvement. In this article, the literature on the treatment of patients with AA is reviewed, emphasizing randomized trials and key retrospective studies. The role of surgery, radiation therapy, and chemotherapy in newly diagnosed patients and those with recurrent disease is described. Basic science insights, advances in neuroimaging and neuropathology, and novel therapies targeting invasion, angiogenesis, and growth modulation will hopefully lead to improved outcome in this subset of patients with malignant glioma. Copyright © 2001 by W.B. Saunders Company.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 46 条
[1]   Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications [J].
Black, PM ;
Moriarty, T ;
Alexander, E ;
Stieg, P ;
Woodard, EJ ;
Gleason, PL ;
Martin, CH ;
Kikinis, R ;
Schwartz, RB ;
Jolesz, FA .
NEUROSURGERY, 1997, 41 (04) :831-842
[2]  
BRADA M, 1998, P AN M AM SOC CLIN, V17, P400
[3]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[4]   SUPRATENTORIAL GLIOMAS - SURGICAL CONSIDERATIONS AND IMMEDIATE POSTOPERATIVE RESULTS - GROSS TOTAL RESECTION VERSUS PARTIAL RESECTION [J].
CIRIC, I ;
AMMIRATI, M ;
VICK, N ;
MIKHAEL, M .
NEUROSURGERY, 1987, 21 (01) :21-26
[5]  
CURRAN WJ, 1992, CANCER, V70, P2909, DOI 10.1002/1097-0142(19921215)70:12<2909::AID-CNCR2820701230>3.0.CO
[6]  
2-6
[7]  
CURRAN WJ, 1992, J NEURO-ONCOL, V12, P219
[8]   RECURSIVE PARTITIONING ANALYSIS OF PROGNOSTIC FACTORS IN 3 RADIATION-THERAPY ONCOLOGY GROUP MALIGNANT GLIOMA TRIALS [J].
CURRAN, WJ ;
SCOTT, CB ;
HORTON, J ;
NELSON, JS ;
WEINSTEIN, AS ;
FISCHBACH, AJ ;
CHANG, CH ;
ROTMAN, M ;
ASBELL, SO ;
KRISCH, RE ;
NELSON, DF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (09) :704-710
[9]   RESULTS OF A RANDOMIZED TRIAL COMPARING BCNU PLUS RADIOTHERAPY, STREPTOZOTOCIN PLUS RADIOTHERAPY, BCNU PLUS HYPERFRACTIONATED RADIOTHERAPY, AND BCNU FOLLOWING MISONIDAZOLE PLUS RADIOTHERAPY IN THE POSTOPERATIVE TREATMENT OF MALIGNANT GLIOMA [J].
DEUTSCH, M ;
GREEN, SB ;
STRIKE, TA ;
BURGER, PC ;
ROBERTSON, JT ;
SELKER, RG ;
SHAPIRO, WR ;
MEALEY, J ;
RANSOHOFF, J ;
PAOLETTI, P ;
SMITH, KR ;
ODOM, GL ;
HUNT, WE ;
YOUNG, B ;
ALEXANDER, E ;
WALKER, MD ;
PISTENMAA, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (06) :1389-1396
[10]  
FINE HA, 1993, CANCER, V71, P2585, DOI 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO